1
P5911 Keratitis, congenital ichthyosis, and neurosensory deafness syndrome with tinea capitis and severe kerion formation Brooke Walls, DO, Nova Southeastern University, Largo, FL, United States Keratitis, congenital ichthyosis, and neurosensory deafness (KID) syndrome is a rare autosomal dominant disorder with a mutation in GJB2, which encodes for connexin 26, a gap junction protein responsible for intercellular communications in the epidermis and cochlea. We report a case of KID syndrome in a 6-year-old African American girl. She presented to our clinic with erythematous, keratotic plaques on the cheeks and a stippled palmoplantar keratoderma. Examination of her scalp revealed large, fungating, malodorous, yellowish-brown hyperkeratotic nodules that were tender and cervical lymphadenopathy. Both the mother and younger brother of our patient presented with similar classic cutaneous findings of KID syndrome, without evidence of severe fungal infection. Recurrent bacterial and fungal infections are a known complication due to the underlying cutaneous abnormality. There have been several reports of squamous cell carcinomas in patients with KID, therefore a low threshold for repeated use of antifungals and biopsy of unusual looking keratotic papules is warranted. Our patient was admitted to the hospital for surgical debridment and IV treatment. Commercial support: None identified. P6072 Loss of genomic DNA copy numbers in the p18, p16, p27, and RB loci in blastic plasmacytoid dendritic cell neoplasm Reiko Morita, PhD, Department of Dermatology, Kinki University Faculty of Medicine, Osakasayama city, Japan; Akira Kawada, PhD, Department of Dermatology, Kinki University Faculty of Medicine, Osakasayama, Japan; Ayaka Hirao, PhD, Department of Dermatology, Kinki University Faculty of Medicine, Osakasayama, Japan; Naoki Oiso, PhD, Department of Dermatology, Kinki University Faculty of Medicine, Osakasayama, Japan; Tomohiko Narita, PhD, Department of Dermatology, Kinki University Faculty of Medicine, Osakasayama, Japan Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare plasmacytoid dendritic cell precursor-derived aggressive neoplasm with poor prognosis. Recently, some studies have indicated that patients with BPDCN have an unusual tumor cell karyotype with an average of 6 to 8 abnormalities. We here report a 74- year-old man with BPDCN. The patient’s genomic DNA copy numbers were analyzed using array-comparative genomic hybridization (CGH) to identify the chromosomal and genetic features of the malignant cells. The array-CGH analysis revealed the loss of the chromosomes1p31.3-33, 9p/q, 12p13.1-13.2 and 13p/q, and the gain of chromosome 16p/q. These lost regions included the loci of the tumor suppressor genes of CDKN2C/p18, CDKN2A/p16, CDKN1B/p27 and RB1, which are known as cell-cycle inhibitors. We identified a novel loss of a chromosome 1p31.3-33 region including CDKN2C/p18, which may be involved in the pathogen- esis of BPDCN. Commercial support: None identified. P7103 Multiple facial angiofibromas revealing Birt-Hogg-Dub e syndrome Fr ed eric Caux, MD, PhD, Reference Center for Genetic Skin Diseases, Bobigny, France; Alexis Guyot, MD, Reference Center for Genetic Skin Diseases, Bobigny, France; Annie L evy, MD, Department of Pathology, Bobigny, France; Jean-Benoit Monfort, MD, Reference Center for Genetic Skin Diseases, Bobigny, France; Liliane Laroche, MD, Reference Center for Genetic Skin Diseases, Bobigny, France; Nadem Soufir, MD, Laboratory of Genetics, Paris, France Angiofibromas are benign cutaneous tumors. Multiple angiofibromas are a hallmark of tuberous sclerosis (Bourneville disease). We reported a patient with numerous facial angiofibromas leading to the diagnosis of Birt-Hogg-Dub e syndrome (BHD). A 37-year-old man was referred with facial skin lesions of 6 years’ duration. His medical history included psoriasis, epilepsy since the age of 27 years and depression treated with valproic acid and escitalopram. Family history indicated that the patient’s father had lung cancer and facial lesions. Clinical examination revealed numerous whitish papules on the nose and the cheeks but no shagreen patch nor hypopigmented macules. Histologic analysis of four facial papules showed three angiofibromas and one fibrous papule. Brain MRI and cardiac and abdominal ultrasound examinations were normal except for a 19-mm renal cyst. Tuberous sclerosis was suspected; genetic analysis of TSC1 and TSC2 genes was performed but no abnormality was found. Association of a renal cyst and multiple facial angiofibromas in this patient led to analyse the FLCN gene and a complete deletion of exon 4 was demonstrated. A diagnosis of Birt-Hogg-Dub e syndrome was finally reached. Additional work-up showed three 5-, 8-, and 9-mm lung cysts on CT scan. Numerous facial angiofibromas are characteristic of tuberous sclerosis. They also have been described in multiple endocrine neoplasia type 1. Only one case of multiple angiofibromas associated with BHD has been reported in the literature. Indeed, cutaneous lesions encountered in BHD are usually whitish or flesh-colored facial papules with histology showing fibrofolliculomas. Other skin lesions of this rare autosomal dominant disease are trichodiscomas and acrochordons. The extra-cutaneous manifestations of BHD include spontaneous pneumothorax and lung cysts and benign or malignant kidney tumors such as oncocytomas and chromophobe renal cell carcinomas. Our patient had molecularly confirmed BHD with typical pulmonary and renal manifestations but the fact this disease was revealed by angiofibromas is exceptional. In summary we reported a case demonstrating that a FLCN gene mutation may be associated with multiple angiofibromas. Consequently, the dermatologist confronted to a patient with numerous angio- fibromas must evoke BHD as well as tuberous sclerosis. Commercial support: None identified. P6186 Netherton syndrome in association with vitamin D deficiency Ashley Delacerda, MD, Scott and White Dermatology, Temple, TX, United States; Karina Parr, MD, Scott and White Dermatology, Temple, TX, United States; Lenore Chiles, MD, Scott and White Dermatalogy, Temple, TX, United States; Matthew Stephen, MD, Scott and White Pediatric Endocrinology Clinic, Temple, TX, United States Netherton syndrome is an autosomal recessive disorder that usually presents with a triad of ichthyosis linearis circumflexa, atopy, and trichorrhexis invaginata. Several other clinical features including delayed growth and bone development and short stature can develop during its clinical course. The disorder is caused by a mutation in the SPINK5 gene important in skin barrier formation and immunity. We report a case of a 10-year-old girl with classic symptoms of congenital Netherton syndrome who developed severe growth retardation and severe vitamin D deficiency. Our patient did not respond well to growth hormone replacement trial by pediatric endocrinology, perhaps due to concomitant vitamin D deficiency. Since patients with Netherton syndrome have several factors predisposing them to the development of vitamin D deficiency with suggest screening these patients with serum vitamin D levels. We compare the current treatment options, which are targeted at minimizing the classic manifes- tations of Netherton syndrome, and consider how Vitamin D supplementation can play a role in the treatment regimen. Commercial support: None identified. APRIL 2013 JAM ACAD DERMATOL AB99

Netherton syndrome in association with vitamin D deficiency

Embed Size (px)

Citation preview

Page 1: Netherton syndrome in association with vitamin D deficiency

P5911Keratitis, congenital ichthyosis, and neurosensory deafness syndromewith tinea capitis and severe kerion formation

Brooke Walls, DO, Nova Southeastern University, Largo, FL, United States

Keratitis, congenital ichthyosis, and neurosensory deafness (KID) syndrome is arare autosomal dominant disorder with a mutation in GJB2, which encodes forconnexin 26, a gap junction protein responsible for intercellular communicationsin the epidermis and cochlea. We report a case of KID syndrome in a 6-year-oldAfrican American girl. She presented to our clinic with erythematous, keratoticplaques on the cheeks and a stippled palmoplantar keratoderma. Examination ofher scalp revealed large, fungating, malodorous, yellowish-brown hyperkeratoticnodules that were tender and cervical lymphadenopathy. Both the mother andyounger brother of our patient presented with similar classic cutaneous findingsof KID syndrome, without evidence of severe fungal infection. Recurrentbacterial and fungal infections are a known complication due to the underlyingcutaneous abnormality. There have been several reports of squamous cellcarcinomas in patients with KID, therefore a low threshold for repeated use ofantifungals and biopsy of unusual looking keratotic papules is warranted. Ourpatient was admitted to the hospital for surgical debridment and IV treatment.

APRIL 20

cial support: None identified.

Commer

P6072Loss of genomic DNA copy numbers in the p18, p16, p27, and RB loci inblastic plasmacytoid dendritic cell neoplasm

Reiko Morita, PhD, Department of Dermatology, Kinki University Faculty ofMedicine, Osakasayama city, Japan; Akira Kawada, PhD, Department ofDermatology, Kinki University Faculty of Medicine, Osakasayama, Japan; AyakaHirao, PhD, Department of Dermatology, Kinki University Faculty of Medicine,Osakasayama, Japan; Naoki Oiso, PhD, Department of Dermatology, KinkiUniversity Faculty of Medicine, Osakasayama, Japan; Tomohiko Narita, PhD,Department of Dermatology, Kinki University Faculty of Medicine, Osakasayama,Japan

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare plasmacytoiddendritic cell precursor-derived aggressive neoplasm with poor prognosis.Recently, some studies have indicated that patients with BPDCN have an unusualtumor cell karyotype with an average of 6 to 8 abnormalities. We here report a 74-year-old man with BPDCN. The patient’s genomic DNA copy numbers wereanalyzed using array-comparative genomic hybridization (CGH) to identify thechromosomal and genetic features of the malignant cells. The array-CGH analysisrevealed the loss of the chromosomes1p31.3-33, 9p/q, 12p13.1-13.2 and 13p/q, andthe gain of chromosome 16p/q. These lost regions included the loci of the tumorsuppressor genes of CDKN2C/p18, CDKN2A/p16, CDKN1B/p27 and RB1, whichare known as cell-cycle inhibitors. We identified a novel loss of a chromosome1p31.3-33 region including CDKN2C/p18, which may be involved in the pathogen-esis of BPDCN.

cial support: None identified.

Commer

13

P7103Multiple facial angiofibromas revealing Birt-Hogg-Dub�e syndrome

Fr�ed�eric Caux, MD, PhD, Reference Center for Genetic Skin Diseases, Bobigny,France; Alexis Guyot, MD, Reference Center for Genetic Skin Diseases, Bobigny,France; Annie L�evy, MD, Department of Pathology, Bobigny, France; Jean-BenoitMonfort, MD, Reference Center for Genetic Skin Diseases, Bobigny, France;Liliane Laroche, MD, Reference Center for Genetic Skin Diseases, Bobigny,France; Nadem Soufir, MD, Laboratory of Genetics, Paris, France

Angiofibromas are benign cutaneous tumors. Multiple angiofibromas are ahallmark of tuberous sclerosis (Bourneville disease). We reported a patient withnumerous facial angiofibromas leading to the diagnosis of Birt-Hogg-Dub�esyndrome (BHD). A 37-year-old man was referred with facial skin lesions of 6years’ duration. His medical history included psoriasis, epilepsy since the age of27 years and depression treated with valproic acid and escitalopram. Familyhistory indicated that the patient’s father had lung cancer and facial lesions.Clinical examination revealed numerous whitish papules on the nose and thecheeks but no shagreen patch nor hypopigmented macules. Histologic analysis offour facial papules showed three angiofibromas and one fibrous papule. BrainMRI and cardiac and abdominal ultrasound examinations were normal except fora 19-mm renal cyst. Tuberous sclerosis was suspected; genetic analysis of TSC1and TSC2 genes was performed but no abnormality was found. Association of arenal cyst and multiple facial angiofibromas in this patient led to analyse theFLCN gene and a complete deletion of exon 4 was demonstrated. A diagnosis ofBirt-Hogg-Dub�e syndrome was finally reached. Additional work-up showed three5-, 8-, and 9-mm lung cysts on CT scan. Numerous facial angiofibromas arecharacteristic of tuberous sclerosis. They also have been described in multipleendocrine neoplasia type 1. Only one case of multiple angiofibromas associatedwith BHD has been reported in the literature. Indeed, cutaneous lesionsencountered in BHD are usually whitish or flesh-colored facial papules withhistology showing fibrofolliculomas. Other skin lesions of this rare autosomaldominant disease are trichodiscomas and acrochordons. The extra-cutaneousmanifestations of BHD include spontaneous pneumothorax and lung cysts andbenign or malignant kidney tumors such as oncocytomas and chromophobe renalcell carcinomas. Our patient had molecularly confirmed BHD with typicalpulmonary and renal manifestations but the fact this disease was revealed byangiofibromas is exceptional. In summary we reported a case demonstrating thata FLCN gene mutation may be associated with multiple angiofibromas.Consequently, the dermatologist confronted to a patient with numerous angio-fibromas must evoke BHD as well as tuberous sclerosis.

cial support: None identified.

Commer

P6186Netherton syndrome in association with vitamin D deficiency

Ashley Delacerda, MD, Scott and White Dermatology, Temple, TX, United States;Karina Parr, MD, Scott and White Dermatology, Temple, TX, United States;Lenore Chiles, MD, Scott and White Dermatalogy, Temple, TX, United States;Matthew Stephen, MD, Scott and White Pediatric Endocrinology Clinic, Temple,TX, United States

Netherton syndrome is an autosomal recessive disorder that usually presents witha triad of ichthyosis linearis circumflexa, atopy, and trichorrhexis invaginata.Several other clinical features including delayed growth and bone developmentand short stature can develop during its clinical course. The disorder is caused bya mutation in the SPINK5 gene important in skin barrier formation and immunity.We report a case of a 10-year-old girl with classic symptoms of congenitalNetherton syndrome who developed severe growth retardation and severevitamin D deficiency. Our patient did not respond well to growth hormonereplacement trial by pediatric endocrinology, perhaps due to concomitantvitamin D deficiency. Since patients with Netherton syndrome have severalfactors predisposing them to the development of vitamin D deficiency withsuggest screening these patients with serum vitamin D levels. We compare thecurrent treatment options, which are targeted at minimizing the classic manifes-tations of Netherton syndrome, and consider how Vitamin D supplementationcan play a role in the treatment regimen.

cial support: None identified.

Commer

J AM ACAD DERMATOL AB99